Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Editorial Group: Cochrane Schizophrenia Group
Published Online: 30 APR 2013
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Adelufosi AO, Abayomi O, Ojo TMF. Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD010501. DOI: 10.1002/14651858.CD010501.
- Publication Status: New
- Published Online: 30 APR 2013
This is the protocol for a review and there is no abstract. The objectives are as follows:
To determine the effects of pyridoxal 5 phosphate (pyridoxine, pyridoxal phosphate, tardoxal) for treating neuroleptic-induced tardive dyskinesia in individuals of any age group with schizophrenia and other psychotic disorders.